BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

433 related articles for article (PubMed ID: 17158551)

  • 1. Outpatient oral antibiotics for febrile neutropenic cancer patients.
    Ouvrier MJ; Thery JC; Blot E
    J Clin Oncol; 2006 Dec; 24(35):5614; author reply 5614-5. PubMed ID: 17158551
    [No Abstract]   [Full Text] [Related]  

  • 2. Outpatient oral antibiotics for febrile neutropenic cancer patients using a score predictive for complications.
    Klastersky J; Paesmans M; Georgala A; Muanza F; Plehiers B; Dubreucq L; Lalami Y; Aoun M; Barette M
    J Clin Oncol; 2006 Sep; 24(25):4129-34. PubMed ID: 16943529
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Feasibility of withholding antibiotics in selected febrile neutropenic cancer patients.
    Oude Nijhuis C; Kamps WA; Daenen SM; Gietema JA; van der Graaf WT; Groen HJ; Vellenga E; Ten Vergert EM; Vermeulen KM; de Vries-Hospers HG; de Bont ES
    J Clin Oncol; 2005 Oct; 23(30):7437-44. PubMed ID: 16234511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk assessment in fever and neutropenia in children with cancer: What did we learn?
    te Poele EM; Tissing WJ; Kamps WA; de Bont ES
    Crit Rev Oncol Hematol; 2009 Oct; 72(1):45-55. PubMed ID: 19195908
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evolving concepts of management of febrile neutropenia in children with cancer.
    Orudjev E; Lange BJ
    Med Pediatr Oncol; 2002 Aug; 39(2):77-85. PubMed ID: 12116054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of the febrile neutropenic patient with cancer.
    Gucalp R
    Oncology (Williston Park); 1991 Jul; 5(7):137-44, 147; discussion 148. PubMed ID: 1837473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The outpatient management of febrile neutropenia in cancer patients.
    Freifeld AG; Pizzo PA
    Oncology (Williston Park); 1996 Apr; 10(4):599-606, 611-2; discussion 615-6. PubMed ID: 8723296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medical and non-medical barriers to outpatient treatment of fever and neutropenia in children with cancer.
    Quezada G; Sunderland T; Chan KW; Rolston K; Mullen CA
    Pediatr Blood Cancer; 2007 Mar; 48(3):273-7. PubMed ID: 16435377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment and prevention of infections in cancer patients with neutropenia].
    Sinkó J
    Magy Onkol; 2011 Sep; 55(3):155-63. PubMed ID: 21918740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral cefixime is similar to continued intravenous antibiotics in the empirical treatment of febrile neutropenic children with cancer.
    Shenep JL; Flynn PM; Baker DK; Hetherington SV; Hudson MM; Hughes WT; Patrick CC; Roberson PK; Sandlund JT; Santana VM; Sixbey JW; Slobod KS
    Clin Infect Dis; 2001 Jan; 32(1):36-43. PubMed ID: 11112678
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Therapeutic approach to a patient with febrile neutropenia].
    Duraković N; Nemet D
    Lijec Vjesn; 2007; 129(10-11):344-50. PubMed ID: 18257335
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Infection in neutropenic patients with cancer.
    Bow EJ
    Crit Care Clin; 2013 Jul; 29(3):411-41. PubMed ID: 23830647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Bacterial infections in neutropenic patients with cancer].
    Matysiak M
    Przegl Lek; 2003; 60 Suppl 5():54-7. PubMed ID: 14575008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of two oral regimens for the outpatient treatment of low-risk cancer patients with chemotherapy-induced neutropenia and fever: ciprofloxacin plus cefuroxime axetil versus ciprofloxacin plus amoxicillin/clavulanate.
    Sipsas NV; Kosmas C; Ziakas PD; Karabelis A; Vadiaka M; Skopelitis E; Kordossis T; Tsavaris N
    Scand J Infect Dis; 2007; 39(9):786-91. PubMed ID: 17701717
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early hospital discharge with oral antimicrobial therapy in patients with hematologic malignancies and low-risk febrile neutropenia.
    Girmenia C; Russo E; Carmosino I; Breccia M; Dragoni F; Latagliata R; Mecarocci S; Morano SG; Stefanizzi C; Alimena G
    Ann Hematol; 2007 Apr; 86(4):263-70. PubMed ID: 17225113
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of the febrile neutropenic patient.
    Picazo JJ;
    Int J Antimicrob Agents; 2005 Dec; 26 Suppl 2():S120-2; discussion S133-40. PubMed ID: 16243492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Withholding antibiotics from patients with febrile neutropenia.
    Lyman GH
    J Clin Oncol; 2006 Mar; 24(7):1221-2; author reply 1222-3. PubMed ID: 16505444
    [No Abstract]   [Full Text] [Related]  

  • 18. Triple combination antimicrobial regimen in the treatment of infections of neutropenic cancer patients.
    Casali A; Santini S; Della Giulia M; Di Lauro L; Vici P; Gionfra T; Sega FM
    J Exp Clin Cancer Res; 1997 Sep; 16(3):321-4. PubMed ID: 9387908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Empirical antimicrobial treatment for chemotherapy-induced febrile neutropenia.
    Bal AM; Gould IM
    Int J Antimicrob Agents; 2007 May; 29(5):501-9. PubMed ID: 17346939
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prophylactic antimicrobial agents and the importance of fitness.
    Baden LR
    N Engl J Med; 2005 Sep; 353(10):1052-4. PubMed ID: 16148291
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 22.